Health
Guillain-Barré syndrome: Why experts are still “confident” in J&J – Inverse
The chances of developing Guillain-Barré Syndrome (GBS) the Johnson & Johnson Covid-19 vaccine are small; what you need to know…
When news broke early this week that there was a possible association
between the Johnson & JohnsonCovid-19 vaccine and rare neurological disorder, people were understandably alarmed. Around 12.5 million people in the United States have received the one-dose…
Continue Reading
-
Noosa News17 hours agoBlute’s Bar Is Picking Up Where The Bearded Lady Left Off, Adding Live Music to Its Late-Night Karaoke Sing-Alongs
-
Business16 hours ago3 ASX 200 shares to buy for the year ahead
-
General21 hours agoTrump meeting cancellation ‘always a chance’: treasurer
-
General15 hours agoIs Australia derivative? | The Spectator Australia